Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

West Pharmaceutical Services, Inc. applies value-added services to the process of bringing new drug therapies and healthcare products to global markets. The Company"s technologies include the design and manufacture of packaging components, research and development of drug delivery systems, and contract laboratory services and other services.
Website: westpharma.com


  • Pretty weak financial results growth rate 6.6% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (5.1%)
  • Dividend yield for the last twelve months 0.3%
  • Free cash flow yield 1.1% (LTM)
  • Share price is 44.8% higher than minimum and 33.3% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (17.3x vs 16.9x)
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: WST
Share price, USD:  (+0.5%)275.6
year average price 251.76  


year start price 327.56 2024-12-31

max close price 347.87 2025-01-22

min close price 190.39 2025-04-08

current price 275.60 2025-12-30
Common stocks: 74 400 000

Dividend Yield:  0.3%
FCF Yield LTM: 1.1%
EV / LTM EBITDA: 17.3x
EV / EBITDA annualized: 23.9x
Last revenue growth (y/y):  +7.8%
Last growth of EBITDA (y/y):  +5.5%
Historical revenue growth:  +1.3%
Historical growth of EBITDA:  +8.9%
EV / Sales: 6.7x
Margin (EBITDA LTM / Revenue): 38.6%

Target EV / EBITDA (hist percentile): 16.9x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 20 505
Net Debt ($m): -331
EV (Enterprise Value): 20 174
EBITDA LTM (млн $): 1 165
EV / LTM EBITDA: 17.3x
Price to Book: 6.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-12-12prnewswire.com

West to Participate in Upcoming Investor Conference

2025-12-11zacks.com

Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now

2025-12-02seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

2025-11-20seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Presents at Stephens Annual Investment Conference 2025 Transcript

2025-10-24prnewswire.com

West to Participate in Upcoming Investor Conferences

2025-10-23seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings Call Transcript

2025-10-23zacks.com

West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates

2025-09-24seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Presents at Bank of America Global Healthcare Conference 2025 Transcript

2025-09-11zacks.com

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

2025-08-21prnewswire.com

West to Participate in Upcoming Investor Conferences in September 2025
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol WST WST WST WST WST WST WST WST WST WST WST
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770
fillingDate 2025-10-23 2025-07-24 2024-10-24 2024-07-25 2024-04-25 2024-02-20 2023-10-26 2023-07-27 2023-04-27 2023-02-21 2022-10-27
acceptedDate 2025-10-23 16:14:52 2025-07-24 16:22:04 2024-10-24 16:21:38 2024-07-25 16:10:57 2024-04-25 16:24:24 2024-02-20 16:44:29 2023-10-26 16:26:21 2023-07-27 16:16:35 2023-04-27 16:10:11 2023-02-21 16:18:23 2022-10-27 16:21:38
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 804M 766M 747M 702M 695M 732M 747M 754M 717M 709M 687M
costOfRevenue 511M 493M 482M 471M 465M 454M 459M 462M 445M 447M 419M
grossProfit 294M 273M 265M 231M 230M 278M 288M 291M 271M 262M 268M
grossProfitRatio 0.365 0.357 0.354 0.329 0.331 0.38 0.386 0.387 0.379 0.37 0.39
researchAndDevelopmentExpenses 17M 19M 16M 18M 18M 18M 16M 17M 17M 16M 14M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 103M 96M 84M 83M 87M 90M 89M 88M 86M 86M 66M
otherExpenses 0 0 0 3M -3M -1M -2M -4M 13M 31M 0
operatingExpenses 120M 115M 99M 101M 107M 108M 105M 105M 116M 132M 80M
costAndExpenses 631M 608M 581M 571M 573M 562M 565M 567M 561M 579M 499M
interestIncome 5M 4M 5M 4M 6M 9M -9M 5M 5M 3M 2M
interestExpense 100 000 100 000 700 000 2M 2M 1M 3M 3M 2M 2M 2M
depreciationAndAmortization 43M 41M 40M 39M 36M 36M 36M 34M 32M 31M 34M
ebitda 217M 199M 205M 168M 158M 214M 219M 221M 187M 130M 173M
ebitdaratio 0.27 0.259 0.275 0.242 0.228 0.292 0.292 0.293 0.261 0.183 0.252
operatingIncome 174M 158M 161M 131M 123M 161M 177M 183M 155M 99M 139M
operatingIncomeRatio 0.216 0.206 0.216 0.186 0.177 0.22 0.237 0.242 0.217 0.139 0.203
totalOtherIncomeExpensesNet 300 000 4M 3M 7M 5M -10M -2M -4M 3M 30M -3M
incomeBeforeTax 174M 162M 165M 129M 127M 168M 187M 185M 158M 129M 136M
incomeBeforeTaxRatio 0.216 0.211 0.22 0.183 0.183 0.23 0.25 0.245 0.22 0.182 0.198
incomeTaxExpense 34M 30M 32M 22M 16M 35M 29M 35M 24M 29M 20M
netIncome 140M 132M 136M 111M 115M 137M 161M 155M 140M 103M 121M
netIncomeRatio 0.174 0.172 0.182 0.159 0.166 0.187 0.216 0.206 0.195 0.145 0.176
eps 1.94 1.82 1.87 1.52 1.57 1.85 2.17 2.08 1.88 1.38 1.62
epsdiluted 1.92 1.82 1.85 1.51 1.55 1.83 2.14 2.06 1.85 1.36 1.59
weightedAverageShsOut 72M 72M 73M 73M 74M 74M 74M 74M 75M 74M 74M
weightedAverageShsOutDil 73M 73M 73M 74M 74M 75M 75M 75M 76M 76M 76M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol WST WST WST WST WST WST WST WST WST WST WST
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770
fillingDate 2025-10-23 2025-07-24 2024-10-24 2024-07-25 2024-04-25 2024-02-20 2023-10-26 2023-07-27 2023-04-27 2023-02-21 2022-10-27
acceptedDate 2025-10-23 16:14:52 2025-07-24 16:22:04 2024-10-24 16:21:38 2024-07-25 16:10:57 2024-04-25 16:24:24 2024-02-20 16:44:29 2023-10-26 16:26:21 2023-07-27 16:16:35 2023-04-27 16:10:11 2023-02-21 16:18:23 2022-10-27 16:21:38
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 629M 510M 491M 446M 602M 854M 899M 796M 886M 894M 729M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 629M 510M 491M 446M 602M 854M 899M 796M 886M 894M 729M
netReceivables 653M 582M 524M 502M 524M 512M 519M 534M 513M 507M 485M
inventory 438M 421M 401M 419M 430M 435M 432M 449M 447M 415M 413M
otherCurrentAssets 104M 168M 134M 116M 137M 136M 123M 94M 91M 103M 106M
totalCurrentAssets 1 823M 1 681M 1 551M 1 483M 1 693M 1 936M 1 972M 1 874M 1 937M 1 920M 1 734M
propertyPlantEquipmentNet 3 331M 1 826M 1 711M 1 635M 1 545M 1 513M 1 408M 1 361M 1 316M 1 263M 1 156M
goodwill 111M 111M 109M 107M 108M 109M 107M 108M 108M 107M 104M
intangibleAssets 9M 10M 12M 13M 14M 15M 16M 17M 18M 18M 18M
goodwillAndIntangibleAssets 120M 121M 121M 120M 122M 124M 123M 125M 126M 126M 122M
longTermInvestments 221M 225M 218M 198M 203M 210M 195M 203M 209M 205M 189M
taxAssets 28M 30M 38M 34M 21M 26M 17M 67M 99M 66M 63M
otherNonCurrentAssets -1 417M 71M 37M 19M 19M 21M 39M 40M 37M 38M 54M
totalNonCurrentAssets 2 283M 2 272M 2 125M 2 006M 1 909M 1 893M 1 782M 1 795M 1 786M 1 697M 1 583M
otherAssets 0 0 0 0 0 0 0 0 0 0 0
totalAssets 4 106M 3 953M 3 675M 3 489M 3 602M 3 830M 3 755M 3 670M 3 724M 3 617M 3 317M
accountPayables 256M 239M 224M 212M 240M 242M 220M 218M 234M 215M 189M
shortTermDebt 23M 21M 20M 154M 151M 152M 72M 18M 18M 18M 16M
taxPayables 33M 29M 33M 17M 17M 31M 15M 27M 59M 39M 30M
deferredRevenue 0 0 0 17M 17M 42M 15M 27M 0 57M 0
otherCurrentLiabilities 323M 316M 239M 251M 240M 236M 227M 249M 283M 228M 252M
totalCurrentLiabilities 635M 605M 517M 634M 648M 672M 534M 512M 535M 519M 457M
longTermDebt 280M 282M 285M 160M 155M 157M 235M 293M 296M 300M 284M
deferredRevenueNonCurrent 0 0 2M 87M 48M 48M 2M 48M 0 0 0
deferredTaxLiabilitiesNonCurrent 23M 23M 9M 14M 13M 13M 17M 15M 15M 14M 17M
otherNonCurrentLiabilities 116M 114M 112M 105M 58M 59M 100M 55M 102M 99M 185M
totalNonCurrentLiabilities 419M 419M 407M 279M 273M 277M 353M 411M 413M 413M 389M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 77M 101M 102M 108M 100M 102M 100M 104M 106M 109M 91M
totalLiabilities 1 054M 1 024M 923M 913M 922M 949M 887M 923M 947M 932M 846M
preferredStock 0 0 0 0 0 0 0 0 0 0 0
commonStock 19M 19M 19M 19M 19M 19M 19M 19M 19M 19M 19M
retainedEarnings 4 262M 4 139M 3 857M 3 721M 3 624M 3 523M 3 416M 3 255M 3 114M 2 988M 2 913M
accumulatedOtherComprehensiveIncomeLoss -102M -89M -136M -217M -192M -144M -223M -184M -168M -183M -309M
othertotalStockholdersEquity -1 127M -1 140M -987M -946M -770M -517M -344M -343M -188M -139M -153M
totalStockholdersEquity 3 052M 2 929M 2 752M 2 577M 2 681M 2 881M 2 868M 2 747M 2 776M 2 685M 2 471M
totalEquity 3 052M 2 929M 2 752M 2 577M 2 681M 2 881M 2 868M 2 747M 2 776M 2 685M 2 471M
totalLiabilitiesAndStockholdersEquity 4 106M 3 953M 3 675M 3 489M 3 602M 3 830M 3 755M 3 670M 3 724M 3 617M 3 317M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 4 106M 3 953M 3 675M 3 489M 3 602M 3 830M 3 755M 3 670M 3 724M 3 617M 3 317M
totalInvestments 221M 225M 218M 198M 203M 210M 195M 203M 209M 205M 189M
totalDebt 303M 303M 305M 314M 307M 309M 307M 311M 314M 318M 300M
netDebt -326M -206M -186M -132M -295M -545M -592M -485M -572M -576M -429M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol WST WST WST WST WST WST WST WST WST WST WST
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770 105 770
fillingDate 2025-10-23 2025-07-24 2024-10-24 2024-07-25 2024-04-25 2024-02-20 2023-10-26 2023-07-27 2023-04-27 2023-02-21 2022-10-27
acceptedDate 2025-10-23 16:14:52 2025-07-24 16:22:04 2024-10-24 16:21:38 2024-07-25 16:10:57 2024-04-25 16:24:24 2024-02-20 16:44:29 2023-10-26 16:26:21 2023-07-27 16:16:35 2023-04-27 16:10:11 2023-02-21 16:18:23 2022-10-27 16:21:38
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome 140M 132M 136M 111M 115M 137M 161M 155M 140M 103M 121M
depreciationAndAmortization 43M 41M 40M 39M 36M 36M 36M 34M 32M 31M 30M
deferredIncomeTax 0 0 0 0 0 23M -192M 4M 0 -31M 0
stockBasedCompensation 8M 7M 5M 4M 5M 1M 6M 8M 9M 7M 6M
changeInWorkingCapital 2M -100 000 -100 000 14M -35M 27M 25M -25M -47M 118M -32M
accountsReceivables 0 0 0 0 0 4M 0 0 0 -36M 0
inventory 0 0 0 0 0 -14M 0 0 0 -50M 0
accountsPayables 0 0 0 0 0 10M 0 0 0 -3M 0
otherWorkingCapital 2M -100 000 -100 000 14M -35M 27M 25M 0 0 206M 0
otherNonCashItems 4M -3M -1M 79M -4M 15M 194M -6M 5M 3M 44M
netCashProvidedByOperatingActivities 197M 177M 180M 165M 118M 239M 230M 169M 138M 231M 169M
investmentsInPropertyPlantAndEquipment -63M -75M -81M -100M -91M -109M -96M -75M -82M -95M -58M
acquisitionsNet 0 0 0 0 0 0 0 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 -800 000 -1 000 000 0 -100 000 100 000 -7M 0 100 000 -59M
netCashUsedForInvestingActivites -63M -75M -82M -101M -91M -109M -96M -82M -82M -95M -59M
debtRepayment -300 000 -300 000 -4M -23M -600 000 -600 000 -600 000 -500 000 -600 000 -600 000 -43M
commonStockIssued 4M 0 0 0 17M 3M 20M 0 0 0 0
commonStockRepurchased 0 -500 000 -52M -187M -272M -177M -28M -174M -72M 100 000 -28M
dividendsPaid -15M -15M -15M -15M -15M -15M -14M -14M -14M -14M -14M
otherFinancingActivites -100 000 1 000 000 6M 7M -100 000 -100 000 -300 000 12M 15M 5M 8M
netCashUsedProvidedByFinancingActivities -12M -15M -64M -218M -271M -190M -22M -177M -71M -10M -75M
effectOfForexChangesOnCash -4M 19M 11M -1M -9M 15M -10M -300 000 7M 39M -24M
netChangeInCash 119M 106M 45M -156M -252M -45M -566M -90M -8M 165M 11M
cashAtEndOfPeriod 629M 510M 491M 446M 602M 854M 230M 796M 886M 894M 729M
cashAtBeginningOfPeriod 510M 404M 446M 602M 854M 899M 796M 886M 894M 729M 719M
operatingCashFlow 197M 177M 180M 165M 118M 239M 230M 169M 138M 231M 169M
capitalExpenditure -63M -75M -81M -100M -91M -109M -96M -75M -82M -95M -58M
freeCashFlow 134M 102M 99M 65M 28M 130M 134M 94M 56M 136M 111M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Earning call transcript

2025 q3
2025-10-23 ET (fiscal 2025 q3)
2025 q2
2025-07-24 ET (fiscal 2025 q2)
2025 q1
2025-04-24 ET (fiscal 2025 q1)
2024 q4
2025-02-13 ET (fiscal 2024 q4)
2024 q3
2024-10-24 ET (fiscal 2024 q3)
2024 q2
2024-07-25 ET (fiscal 2024 q2)
2024 q1
2024-04-25 ET (fiscal 2024 q1)
2023 q4
2024-02-15 ET (fiscal 2023 q4)
2023 q3
2023-10-26 ET (fiscal 2023 q3)
2023 q2
2023-07-27 ET (fiscal 2023 q2)
2023 q1
2023-04-27 ET (fiscal 2023 q1)
2022 q4
2023-02-16 ET (fiscal 2022 q4)
2022 q3
2022-10-27 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-04-28 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-10-23 20:14 ET
West Pharmaceutical Services reported for 2025 q3
SEC form 8
2025-10-23 11:15 ET
West Pharmaceutical Services published news for 2025 q3
SEC form 8
2025-10-23 11:15 ET
West Pharmaceutical Services published news for 2025 q3
SEC form 8
2025-10-23 11:15 ET
West Pharmaceutical Services published news for 2025 q3
SEC form 10
2025-07-24 20:22 ET
West Pharmaceutical Services reported for 2025 q2
SEC form 8
2025-07-24 11:17 ET
West Pharmaceutical Services published news for 2025 q2
SEC form 8
2025-07-24 11:17 ET
West Pharmaceutical Services published news for 2025 q2
SEC form 8
2025-07-24 11:17 ET
West Pharmaceutical Services published news for 2025 q2
SEC form 8
2025-05-08 20:46 ET
West Pharmaceutical Services published news for 2025 q1
SEC form 8
2025-05-08 20:46 ET
West Pharmaceutical Services published news for 2025 q1
SEC form 10
2025-04-24 20:19 ET
West Pharmaceutical Services reported for 2025 q1
SEC form 8
2025-04-24 11:47 ET
West Pharmaceutical Services published news for 2025 q1
SEC form 8
2025-04-24 11:47 ET
West Pharmaceutical Services published news for 2025 q1
SEC form 8
2025-04-24 11:47 ET
West Pharmaceutical Services published news for 2025 q1
SEC form 10
2025-04-24 00:00 ET
West Pharmaceutical Services published news for 2025 q1
SEC form 10
2025-02-18 21:44 ET
West Pharmaceutical Services published news for 2024 q4
SEC form 10
2025-02-18 00:00 ET
West Pharmaceutical Services published news for 2024 q4
SEC form 8
2025-02-13 08:00 ET
West Pharmaceutical Services published news for 2024 q4
SEC form 8
2025-02-13 08:00 ET
West Pharmaceutical Services reported for 2024 q4
SEC form 8
2025-02-13 08:00 ET
West Pharmaceutical Services published news for 2024 q4
SEC form 10
2024-10-24 16:21 ET
West Pharmaceutical Services reported for 2024 q3
SEC form 8
2024-10-24 07:50 ET
West Pharmaceutical Services published news for 2024 q3
SEC form 8
2024-10-24 07:50 ET
West Pharmaceutical Services published news for 2024 q3
SEC form 8
2024-10-24 07:50 ET
West Pharmaceutical Services published news for 2024 q3
SEC form 10
2024-10-24 00:00 ET
West Pharmaceutical Services published news for 2024 q3
SEC form 10
2024-07-25 16:10 ET
West Pharmaceutical Services published news for 2024 q2
SEC form 8
2024-07-25 08:05 ET
West Pharmaceutical Services published news for 2024 q2
SEC form 8
2024-07-25 08:05 ET
West Pharmaceutical Services reported for 2024 q2
SEC form 8
2024-07-25 08:05 ET
West Pharmaceutical Services published news for 2024 q2
SEC form 10
2024-07-25 00:00 ET
West Pharmaceutical Services published news for 2024 q2
SEC form 10
2024-04-25 16:24 ET
West Pharmaceutical Services published news for 2024 q1
SEC form 8
2024-04-25 07:42 ET
West Pharmaceutical Services published news for 2024 q1
SEC form 8
2024-04-25 07:42 ET
West Pharmaceutical Services reported for 2024 q1
SEC form 8
2024-04-25 07:42 ET
West Pharmaceutical Services published news for 2024 q1
SEC form 10
2024-04-25 00:00 ET
West Pharmaceutical Services published news for 2024 q1
SEC form 10
2024-02-20 00:00 ET
West Pharmaceutical Services published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
West Pharmaceutical Services published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
West Pharmaceutical Services reported for 2023 q4
SEC form 8
2024-02-15 00:00 ET
West Pharmaceutical Services published news for 2023 q4
SEC form 10
2023-10-26 16:26 ET
West Pharmaceutical Services published news for 2023 q3
SEC form 8
2023-10-26 07:41 ET
West Pharmaceutical Services reported for 2023 q3
SEC form 10
2023-10-26 00:00 ET
West Pharmaceutical Services published news for 2023 q3
SEC form 10
2023-07-27 16:16 ET
West Pharmaceutical Services published news for 2023 q2
SEC form 6
2023-07-27 07:46 ET
West Pharmaceutical Services reported for 2023 q2
SEC form 10
2023-07-27 00:00 ET
West Pharmaceutical Services published news for 2023 q2
SEC form 8
2023-07-27 00:00 ET
West Pharmaceutical Services published news for 2023 q2
SEC form 6
2023-06-28 16:07 ET
West Pharmaceutical Services published news for 2023 q1
SEC form 6
2023-06-28 16:06 ET
West Pharmaceutical Services published news for 2023 q1
SEC form 10
2023-04-27 00:00 ET
West Pharmaceutical Services published news for 2023 q1
SEC form 8
2023-04-27 00:00 ET
West Pharmaceutical Services published news for 2023 q1
SEC form 10
2023-02-21 16:18 ET
West Pharmaceutical Services reported for 2022 q4
SEC form 10
2023-02-21 00:00 ET
West Pharmaceutical Services reported for 2022 q4
SEC form 6
2023-02-16 07:40 ET
West Pharmaceutical Services published news for 2022 q4
SEC form 8
2023-02-16 00:00 ET
West Pharmaceutical Services reported for 2022 q4
SEC form 10
2022-10-27 16:21 ET
West Pharmaceutical Services reported for 2022 q3
SEC form 6
2022-10-27 07:50 ET
West Pharmaceutical Services published news for 2022 q3
SEC form 10
2022-10-27 00:00 ET
West Pharmaceutical Services reported for 2022 q3
SEC form 8
2022-10-27 00:00 ET
West Pharmaceutical Services reported for 2022 q3
SEC form 10
2022-07-28 16:04 ET
West Pharmaceutical Services reported for 2022 q2
SEC form 6
2022-07-28 07:37 ET
West Pharmaceutical Services published news for 2022 q2
SEC form 10
2022-07-28 00:00 ET
West Pharmaceutical Services reported for 2022 q2
SEC form 8
2022-07-28 00:00 ET
West Pharmaceutical Services reported for 2022 q2
SEC form 6
2022-07-27 07:37 ET
West Pharmaceutical Services published news for 2022 q2
SEC form 6
2022-06-23 16:17 ET
West Pharmaceutical Services published news for 2022 q1
SEC form 6
2022-06-23 16:16 ET
West Pharmaceutical Services published news for 2022 q1
SEC form 6
2022-05-26 16:07 ET
West Pharmaceutical Services published news for 2022 q1
SEC form 6
2022-05-12 16:32 ET
West Pharmaceutical Services published news for 2022 q1
SEC form 10
2022-04-28 16:04 ET
West Pharmaceutical Services reported for 2022 q1
SEC form 6
2022-04-28 07:52 ET
West Pharmaceutical Services published news for 2022 q1
SEC form 10
2022-04-28 00:00 ET
West Pharmaceutical Services reported for 2022 q1
SEC form 8
2022-04-28 00:00 ET
West Pharmaceutical Services reported for 2022 q1
SEC form 6
2022-04-14 09:00 ET
West Pharmaceutical Services published news for 2022 q1
SEC form 6
2022-04-01 16:11 ET
West Pharmaceutical Services published news for 2022 q1
SEC form 6
2022-02-28 17:01 ET
West Pharmaceutical Services published news for 2021 q4
SEC form 10
2022-02-22 16:22 ET
West Pharmaceutical Services published news for 2021 q4
SEC form 10
2022-02-22 00:00 ET
West Pharmaceutical Services published news for 2021 q4
SEC form 6
2022-02-17 07:51 ET
West Pharmaceutical Services published news for 2021 q4
SEC form 8
2022-02-17 00:00 ET
West Pharmaceutical Services published news for 2021 q4
SEC form 10
2021-10-28 16:01 ET
West Pharmaceutical Services published news for 2021 q3
SEC form 6
2021-10-28 08:17 ET
West Pharmaceutical Services published news for 2021 q3
SEC form 10
2021-10-28 00:00 ET
West Pharmaceutical Services published news for 2021 q3
SEC form 8
2021-10-28 00:00 ET
West Pharmaceutical Services published news for 2021 q3
SEC form 6
2021-08-24 08:40 ET
West Pharmaceutical Services published news for 2021 q2
SEC form 6
2021-08-23 16:40 ET
West Pharmaceutical Services published news for 2021 q2
SEC form 10
2021-07-30 07:58 ET
West Pharmaceutical Services published news for 2021 q2
SEC form 10
2021-07-30 00:00 ET
West Pharmaceutical Services published news for 2021 q2
SEC form 6
2021-07-29 08:07 ET
West Pharmaceutical Services published news for 2021 q2
SEC form 8
2021-07-29 00:00 ET
West Pharmaceutical Services published news for 2021 q2
SEC form 6
2021-06-24 16:46 ET
West Pharmaceutical Services published news for 2021 q1
SEC form 6
2021-06-24 16:45 ET
West Pharmaceutical Services published news for 2021 q1
SEC form 6
2021-05-06 17:01 ET
West Pharmaceutical Services published news for 2021 q1
SEC form 10
2021-04-30 16:03 ET
West Pharmaceutical Services published news for 2021 q1
SEC form 10
2021-04-30 00:00 ET
West Pharmaceutical Services published news for 2021 q1
SEC form 6
2021-04-29 20:34 ET
West Pharmaceutical Services published news for 2021 q1
SEC form 6
2021-04-29 07:20 ET
West Pharmaceutical Services published news for 2021 q1
SEC form 8
2021-04-29 00:00 ET
West Pharmaceutical Services published news for 2021 q1
SEC form 6
2021-03-24 07:00 ET
West Pharmaceutical Services published news for 2020 q4
SEC form 6
2021-03-01 16:06 ET
West Pharmaceutical Services published news for 2020 q4
SEC form 10
2021-02-23 16:49 ET
West Pharmaceutical Services published news for 2020 q4
SEC form 6
2021-02-18 07:39 ET
West Pharmaceutical Services published news for 2020 q4
SEC form 6
2020-12-09 07:54 ET
West Pharmaceutical Services published news for 2020 q3
SEC form 6
2020-11-09 16:50 ET
West Pharmaceutical Services published news for 2020 q3
SEC form 6
2020-10-28 08:41 ET
West Pharmaceutical Services published news for 2020 q3
SEC form 10
2020-10-23 16:03 ET
West Pharmaceutical Services published news for 2020 q3
SEC form 6
2020-10-22 07:34 ET
West Pharmaceutical Services published news for 2020 q3